Loading provider…
Loading provider…
Neurology Physician in San Diego, CA
NPI: 1134167141Primary Employer
UCSD Medical Group
health.ucsd.edu
HQ Phone
Get M.D. Stephanie's Phone Numberphone_androidMobile
Get M.D. Stephanie's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
2002 - 2026

American Board of Psychiatry and Neurology
Neurology
University of California (San Diego) Medical Center
Residency • Neurology
2002 - 2005
Sutter Health/California Pacific Medical Center
Internship • Internal Medicine
2001 - 2002
Renaissance School of Medicine at Stony Brook University
stonybrook.edu
Medical School
Until 2001
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 192 | 360 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 49 | 65 |
| 3 | 99204New patient office or other outpatient visit, 45-59 minutes | 32 | 32 |
| 4 | J0585Injection, onabotulinumtoxina, 1 unit | 31 | 13,880 |
| 5 | 95970Electronic analysis of implanted brain spinal cord or peripheral neurostimulator generator system | 28 | 45 |
Delineation of Apathy Subgroups in Parkinson's Disease: Differences in Clinical Presentation, Functional Ability, Health-related Quality of Life, and Caregiver Burden
Authors: Irene Litvan
Publication Date: 2021-01
The relationship between objective and subjective executive function in Parkinson's disease.
Lead Sponsor: Ken Marek, MD
Collaborators: Institute for Neurodegenerative Disorders
Intervention / Treatment: DRUG: DaTscan
Lead Sponsor: Medivation, Inc.
Collaborators: Huntington Study Group
Intervention / Treatment: OTHER: Placebo, DRUG: Dimebon
Lead Sponsor: Medivation, Inc.
Collaborators: Huntington Study Group
Intervention / Treatment: DRUG: Dimebon